About us
Patients and carers
Healthcare professionals
Product portfolio
Report adverse event
Newsroom
Investors
Business development

About us
Patients and carers
Healthcare professionals
Product portfolio
Report adverse event
Newsroom
Investors
Business development

Share price information

Amryt Pharma is traded on Nasdaq

ADS Conversion Frequently Asked Questions

Download ADS Conversion Frequently Asked Questions document >>

We transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those in greatest need.

Privacy policy | Terms and Conditions | Modern Slavery Statement
Cookie policy | Fraud warning
Accessibility | Sitemap

Copyright © 2023 Amryt Pharma plc

Amryt Pharma has been acquired by Chiesi Farmaceutici S.p.A. View the press release to learn more.